Skip to content

Evaluation of the mobility assessement CHARMI® during inpatient neurological rehabilitation (phase C) in stroke patients

Evaluation of the mobility assessement CHARMI® during inpatient neurological rehabilitation (phase C) in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031764
Enrollment
23
Registered
2023-08-14
Start date
2023-09-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke patients

Interventions

Group 1: stroke patients in neurological rehabilitation clinic (phase C)

Sponsors

Kliniken Beelitz GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - ischaemic or haemorrhagic stroke - patients in late neurological rehabilitation (phase C) - first visit ( V1) within 6 weeks poststroke - age =18 years

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
-CHARMI at admission (visit 1) -Barthel Index (validity) at admission

Secondary

MeasureTime frame
-CHARMI at visit 2 (re-assessment 3 weeks after admission) -length of hospital stay (acute hospital, phase B, phase C) -self-assessment of mobility at visit 2 -global cognition (MMSE) at visit 1

Countries

Germany

Contacts

Public ContactAnna Gorsler

Kliniken Beelitz GmbH

gorsler@kliniken-beelitz.de+49 33204 - 22305

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026